Coordinated facilities requirements for FY25 - facilities to i
Active Awarded Last action
- Contract number
- 75N91025F00015
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,054,787
Award facts
- Opportunity
-
- NCINCIFOSO250117 Solicitation number
- Contract value 94% obligated
-
- $15,054,787.00 Current, with exercised options
- $15,990,578.00 Potential, with all options
- Completion date 22% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
This is a $15,990,578.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. The contract is for coordinated facilities requirements and support services for the NCI through September 2030. This contract is not set aside for any specific business category.
Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing comprehensive biomedical research and facilities support services. The company has extensive experience supporting critical scientific research across multiple disease areas, including cancer, HIV/AIDS, influenza, COVID-19, and gene therapy. The contract will likely involve activities such as facility improvements, infrastructure projects, clinical trial support, vaccine development, and specialized research initiatives to support the NCI's mission.
Quick answers
Who was awarded contract 75N91025F00015?
75N91025F00015 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2025.
How much is contract 75N91025F00015 worth?
The government has obligated $15,054,787 on 75N91025F00015. Its potential value, with all options, is $15,990,578.
Is contract 75N91025F00015 an order under another contract?
Yes. 75N91025F00015 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91025F00015 competed?
The extent of competition for 75N91025F00015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award